Hepatitis B and C Diagnostics Market by Type, Disease Type, and Geography - Forecast and Analysis 2023-2027

Published: Dec 2022 Pages: 161 SKU: IRTNTR70927

Hepatitis B and C Diagnostics Market Forecast 2023-2027

The hepatitis B and C diagnostics market size is estimated to increase by USD 2,055.79 million between 2022 and 2027, at a CAGR of 6.12%. The growth of the market depends on several factors, including growing demand for molecular diagnostics in the diagnosis of HBV and HCV, strategies of healthcare organizations toward simplifying the diagnostic process, and rising demand for POC diagnostics.

What will be the size of the Hepatitis B And C Diagnostics Market During the Forecast Period?

To learn more about this report, Download Market Research Report Sample PDF

The reports categorize global market as a part of the global life sciences tools and services market. The parent, global life sciences tools and services market covers products and companies engaged in research and development (R&D) of a variety of product categories, including capital equipment, instruments, accessories, and consumables that are used for R&D on pharmaceuticals and biotechnology products and laboratory diagnosis of various diseases.  Our market research report has extensively covered external factors influencing the parent market growth during the forecast period.

Market Dynamics

The growing demand for molecular diagnostics in the diagnosis of HBV and HCV is notably driving the market growth, although factors such as low penetration of HBV and HCV diagnostic tests may impede the market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

The growing demand for molecular diagnostics in the diagnosis of HBV and HCV is notably driving market growth. Globally, nearly 600 hospital laboratories and 200 independent laboratories undertake high-volume testing that requires automated molecular diagnostic testing platforms to simplify and facilitate sample preparation. The popular applications of molecular diagnostics include the identification and profiling of causative agents of infection and the quantification of pathogens to monitor the durability of therapy.

The sales of molecular diagnostics for infectious diseases, such as HBV and HCV, hold a major share of the overall molecular diagnostics market. Real-time polymerase chain reaction (PCR) is the standard recommended molecular diagnostics method for HCV RNA and HBV DNA in clinical samples. Hence, the huge potential for the application of molecular biology techniques in the clinical diagnosis of HBV and HCV will drive the growth of the market during the forecast period.

Significant Trends

High demand for biomarker-based tests is the primary trend in the market. Biomarkers are proteins, genes, hormones, and other molecular entities that detect the absence or presence of a disease. Sophisticated R&D in proteomics, nucleic acid expression, and genome sequencing has led to the emergence of molecular biomarkers. Technological advancements are driving manufacturers to develop assays that identify biomarkers in high-growth clinical areas such as infectious diseases, including hepatitis and retroviruses.

Biomarker-based tests will likely replace conventional drug therapeutics and account for increased revenue and sales from personalized test devices. To better reach the market, companies are developing cost-effective biomarker-based tests. Increased approvals for medical devices and a rise in product launches are expected to propel the market growth during the forecast period.

Major Challenge

Low penetration of HBV and HCV diagnostic tests is one of the challenges impeding market growth. The presence of a large population of undiagnosed individuals with hepatitis C infections indicates a low penetration of the diagnostics. According to the World Hepatitis Alliance, only around 5% of individuals with the conditions in low-income countries are diagnosed.

The low penetration could be due to the lack of awareness and appropriate tools, as well as delivery issues. For instance, less than 1% of these individuals are likely to be aware of their diagnosis. Some other major issues are the absence of government policies and the lack of funding from government agencies. Furthermore, these diagnostics are costly, which affects their adoption rate in low-income countries. Also, treatment regimens are complex, affecting the diagnosis rates. Such issues will hinder the growth of the market during the forecast period.

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Market Customer Landscape

Who are the Major Hepatitis B and C Diagnostics Market Players?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Abbott Laboratories - The company offers hepatitis B and C diagnostics solutions under its brands Alinity and ARCHITECT under the medical devices and pharmaceuticals segment. The company offers products for rhythm management, electrophysiology, heart failure, vascular, structural heart, and neuromodulation.

The market report also includes detailed analyses of the competitive landscape of the market and information about 15 market players, including:

  • Bio Rad Laboratories Inc.
  • bioMerieux SA
  • DAAN Gene Co. Ltd.
  • DiaSorin SpA
  • Enzo Biochem Inc.
  • F. Hoffmann La Roche Ltd.
  • Grifols SA
  • Hologic Inc.
  • MedMira Inc.
  • OraSure Technologies Inc.
  • PerkinElmer Inc.
  • QIAGEN NV
  • Quidel Corp.
  • Randox Laboratories Ltd.
  • Siemens AG
  • Sysmex Corp.
  • Xiamen Innovax Biotech Co. Ltd.

Qualitative and quantitative analysis of vendors has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

What is the Fastest-Growing Segment in the Market?

The market share growth of the immunodiagnostics segment will be significant during the forecast period. Immunodiagnostics are diagnostic tests that detect antigens or antibodies by producing an enzyme-triggered color change. Immunodiagnostics have the highest adoption rates for the diagnosis of the virus (HCV) and the B virus (HBV), owing to their established presence for an extended period.

Get a glance at the market contribution of various segments Request Market Research Report Sample PDF

The immunodiagnostics segment was valued at USD 3,424.50 million in 2017 and continued to grow until 2021. There is an increased need for quantification diagnostic tests owing to their ability to determine the stage of infection. The higher demand for viral core antigen testing, which is essential for effective and accurate diagnosis, is expected to fuel market growth for HCV and HBV immunodiagnostics market.

Which are the Key Regions for the Market?

For more insights on the market share of various regions Request Market Research Report Sample PDF

North America is estimated to contribute 47% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

The market in North America is witnessing high adoption of these tests for HBV. Increasing blood transfusions in North America has driven the need for the diagnosis of the B variant. Around 4.5 million people living in the US and Canada need blood transfusions each year. The implementation of POC testing methods has also increased in the region, as these products are highly accessible and easy to use. Biomarker-based POC tests and initiatives by non-profit and government institutes, such as the National Institute of Health (NIH), are expected to drive market growth.

Segment Overview

The report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Type Outlook (USD Million, 2017 - 2027)
    • Immunodiagnostics
    • NAT
  • Disease Type Outlook (USD Million, 2017 - 2027)
    • Hepatitis B
    • Hepatitis C
  • Region Outlook (USD Million, 2017 - 2027)
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • Asia
      • China
      • India
    • Rest of World (ROW)
      • Brazil
      • Argentina
      • Rest of the Middle East & Africa

Market Analyst Overview

The Hepatitis B and C Diagnostics Market is experiencing significant growth, driven by advancements in technology and a rising demand for efficient diagnostic tools. The market encompasses a range of test types, including blood tests, imaging tests, and liver biopsies, catering to various diagnostic needs. Geographically, North America, Europe, Asia-Pacific, Middle East and Africa, and South America are key regions witnessing substantial market growth. Key industry players such as Transasia Bio-Medicals, Danaher Corporation, and Siemens Healthineers are at the forefront of innovation, with products like the ErbaLisa HCV Gen 4 Ag+Ab testing kit and Elecsys HCV Duo immunoassay. These companies are also actively engaged in partnerships, acquisitions, and product approvals to enhance their market presence.

World Hepatitis Day, recognized by WHO and supported by organizations like the Pan American Health Organization, is pivotal in raising awareness about HBV and HCV. Public Health agencies, including the National Institute of Biologicals (NIB) and the Partnership for Health Advancement in Vietnam (HAIVN), play crucial roles in advancing healthcare infrastructure and promoting diagnostic services.

The competitive landscape includes industry giants such as Gilead Sciences, Inc., Abbott, and Bio-Rad Laboratories Inc., driving market trends through technology innovation and strategic collaborations with institutions like Brigham and Women's Hospital, Harvard Medical School, and Beth Israel Deaconess Medical Center. Overall, the hepatitis diagnostic test market is thriving, with a diverse range of players and technologies contributing to its growth and development, estimated to be in the range of USD million, particularly in regions like India, where healthcare technology and infrastructure are rapidly evolving.

Market Scope

Report Coverage

Details

Page number

161

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Decelerate at a CAGR of 6.12%

Market growth 2023-2027

USD 2,055.79 million

Market structure

Fragmented

YoY growth 2022-2023(%)

6.92

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 47%

Key countries

US, Germany, UK, Japan, and China

Competitive landscape

 Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Bio Rad Laboratories Inc., bioMerieux SA, DAAN Gene Co. Ltd., DiaSorin SpA, Enzo Biochem Inc., F. Hoffmann La Roche Ltd., Grifols SA, Hologic Inc., MedMira Inc., OraSure Technologies Inc., PerkinElmer Inc., QIAGEN NV, Quidel Corp., Randox Laboratories Ltd., Siemens AG, Sysmex Corp., and Xiamen Innovax Biotech Co. Ltd.

Market dynamics

Parent market analysis, Market forecasting, Market growth inducers and obstacles, segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.

Customization purview

If our market growth and trends report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Request Market Research Report Sample PDF

What are the Key Data Covered in this Market Research  Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting of the market between 2023 and 2027
  • Precise estimation of the size of the market size and its contribution to the parent market
  • Accurate predictions about upcoming market trends and analysis and changes in consumer behavior
  • Growth of the market industry across Europe, North America, APAC, South America, and Middle East and Africa
  • Thorough market growth analysis of the market’s competitive landscape and detailed information about vendors
  • Comprehensive market analysis and report on the factors that will challenge the market research and growth of market vendors

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Disease Type
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global hepatitis B and C diagnostics market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on Global hepatitis B and C diagnostics market 2017 - 2021 ($ million)
    • 4.2 Procedure Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Procedure Segment 2017 - 2021 ($ million)
    • 4.3 Diseases Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Diseases Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Type

    • 6.1 Market segments
      • Exhibit 30: Chart on Type - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
    • 6.2 Comparison by Type
      • Exhibit 32: Chart on Comparison by Type
      • Exhibit 33: Data Table on Comparison by Type
    • 6.3 Immunodiagnostics - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Immunodiagnostics - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Immunodiagnostics - Year-over-year growth 2022-2027 (%)
    • 6.4 NAT - Market size and forecast 2022-2027
      • Exhibit 38: Chart on NAT - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on NAT - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on NAT - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on NAT - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Type
      • Exhibit 42: Market opportunity by Type ($ million)

    7 Market Segmentation by Disease Type

    • 7.1 Market segments
      • Exhibit 43: Chart on Disease Type - Market share 2022-2027 (%)
      • Exhibit 44: Data Table on Disease Type - Market share 2022-2027 (%)
    • 7.2 Comparison by Disease Type
      • Exhibit 45: Chart on Comparison by Disease Type
      • Exhibit 46: Data Table on Comparison by Disease Type
    • 7.3 Hepatitis B - Market size and forecast 2022-2027
      • Exhibit 47: Chart on Hepatitis B - Market size and forecast 2022-2027 ($ million)
      • Exhibit 48: Data Table on Hepatitis B - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Chart on Hepatitis B - Year-over-year growth 2022-2027 (%)
      • Exhibit 50: Data Table on Hepatitis B - Year-over-year growth 2022-2027 (%)
    • 7.4 Hepatitis C - Market size and forecast 2022-2027
      • Exhibit 51: Chart on Hepatitis C - Market size and forecast 2022-2027 ($ million)
      • Exhibit 52: Data Table on Hepatitis C - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Chart on Hepatitis C - Year-over-year growth 2022-2027 (%)
      • Exhibit 54: Data Table on Hepatitis C - Year-over-year growth 2022-2027 (%)
    • 7.5 Market opportunity by Disease Type
      • Exhibit 55: Market opportunity by Disease Type ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 57: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 58: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 59: Chart on Geographic comparison
      • Exhibit 60: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 61: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 63: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 64: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 65: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 67: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 68: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 69: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 70: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 71: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 72: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 73: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 74: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 75: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 76: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 77: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 78: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 79: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 80: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 Germany - Market size and forecast 2022-2027
      • Exhibit 81: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 82: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 83: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 84: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.9 UK - Market size and forecast 2022-2027
      • Exhibit 85: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 86: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 87: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 88: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.10 Japan - Market size and forecast 2022-2027
      • Exhibit 89: Chart on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 90: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
      • Exhibit 91: Chart on Japan - Year-over-year growth 2022-2027 (%)
      • Exhibit 92: Data Table on Japan - Year-over-year growth 2022-2027 (%)
    • 9.11 China - Market size and forecast 2022-2027
      • Exhibit 93: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 94: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 95: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 96: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 97: Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 98: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 100: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 101: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 102: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 103: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 104: Abbott Laboratories - Overview
              • Exhibit 105: Abbott Laboratories - Business segments
              • Exhibit 106: Abbott Laboratories - Key news
              • Exhibit 107: Abbott Laboratories - Key offerings
              • Exhibit 108: Abbott Laboratories - Segment focus
            • 12.4 Bio Rad Laboratories Inc.
              • Exhibit 109: Bio Rad Laboratories Inc. - Overview
              • Exhibit 110: Bio Rad Laboratories Inc. - Business segments
              • Exhibit 111: Bio Rad Laboratories Inc. - Key news
              • Exhibit 112: Bio Rad Laboratories Inc. - Key offerings
              • Exhibit 113: Bio Rad Laboratories Inc. - Segment focus
            • 12.5 bioMerieux SA
              • Exhibit 114: bioMerieux SA - Overview
              • Exhibit 115: bioMerieux SA - Product / Service
              • Exhibit 116: bioMerieux SA - Key offerings
            • 12.6 DAAN Gene Co. Ltd.
              • Exhibit 117: DAAN Gene Co. Ltd. - Overview
              • Exhibit 118: DAAN Gene Co. Ltd. - Product / Service
              • Exhibit 119: DAAN Gene Co. Ltd. - Key offerings
            • 12.7 DiaSorin SpA
              • Exhibit 120: DiaSorin SpA - Overview
              • Exhibit 121: DiaSorin SpA - Business segments
              • Exhibit 122: DiaSorin SpA - Key news
              • Exhibit 123: DiaSorin SpA - Key offerings
              • Exhibit 124: DiaSorin SpA - Segment focus
            • 12.8 Enzo Biochem Inc.
              • Exhibit 125: Enzo Biochem Inc. - Overview
              • Exhibit 126: Enzo Biochem Inc. - Product / Service
              • Exhibit 127: Enzo Biochem Inc. - Key offerings
            • 12.9 F. Hoffmann La Roche Ltd.
              • Exhibit 128: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 129: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 130: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 131: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 132: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.10 Grifols SA
              • Exhibit 133: Grifols SA - Overview
              • Exhibit 134: Grifols SA - Business segments
              • Exhibit 135: Grifols SA - Key offerings
              • Exhibit 136: Grifols SA - Segment focus
            • 12.11 Hologic Inc.
              • Exhibit 137: Hologic Inc. - Overview
              • Exhibit 138: Hologic Inc. - Business segments
              • Exhibit 139: Hologic Inc. - Key news
              • Exhibit 140: Hologic Inc. - Key offerings
              • Exhibit 141: Hologic Inc. - Segment focus
            • 12.12 MedMira Inc.
              • Exhibit 142: MedMira Inc. - Overview
              • Exhibit 143: MedMira Inc. - Product / Service
              • Exhibit 144: MedMira Inc. - Key offerings
            • 12.13 OraSure Technologies Inc.
              • Exhibit 145: OraSure Technologies Inc. - Overview
              • Exhibit 146: OraSure Technologies Inc. - Business segments
              • Exhibit 147: OraSure Technologies Inc. - Key offerings
              • Exhibit 148: OraSure Technologies Inc. - Segment focus
            • 12.14 PerkinElmer Inc.
              • Exhibit 149: PerkinElmer Inc. - Overview
              • Exhibit 150: PerkinElmer Inc. - Business segments
              • Exhibit 151: PerkinElmer Inc. - Key news
              • Exhibit 152: PerkinElmer Inc. - Key offerings
              • Exhibit 153: PerkinElmer Inc. - Segment focus
            • 12.15 QIAGEN NV
              • Exhibit 154: QIAGEN NV - Overview
              • Exhibit 155: QIAGEN NV - Product / Service
              • Exhibit 156: QIAGEN NV - Key news
              • Exhibit 157: QIAGEN NV - Key offerings
            • 12.16 Randox Laboratories Ltd.
              • Exhibit 158: Randox Laboratories Ltd. - Overview
              • Exhibit 159: Randox Laboratories Ltd. - Product / Service
              • Exhibit 160: Randox Laboratories Ltd. - Key offerings
            • 12.17 Siemens AG
              • Exhibit 161: Siemens AG - Overview
              • Exhibit 162: Siemens AG - Business segments
              • Exhibit 163: Siemens AG - Key news
              • Exhibit 164: Siemens AG - Key offerings
              • Exhibit 165: Siemens AG - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 166: Inclusions checklist
                • Exhibit 167: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 168: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 169: Research methodology
                • Exhibit 170: Validation techniques employed for market sizing
                • Exhibit 171: Information sources
              • 13.5 List of abbreviations
                • Exhibit 172: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              hepatitis b and c diagnostics market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis